Ulrich FS, Napoli N, Nielsen MF, Burden AM, et al. Real-world persistence and dose titration of GLP-1 receptor agonists in type 2 diabetes: A UK population-based cohort study by obesity and cardiovascular disease status. Diabetes Obes Metab 2026 Feb 17. doi: 10.1111/dom.70535.
PMID: 41703773